Case Studies: Customer Stories
Unique insight into how we work successfully together with our customers
At Quotient Sciences our experienced, expert scientific team are passionate about partnering with customers to solve challenges and deliver new medicines, fast. Case Studies are our strongest evidence of delivering strategic results and solving many complex drug development challenges, for customers, across the biotech and pharmaceutical industry.
Take an in-depth look at a selection of customer case studies that showcase real-world examples of strategic insights, tailored services and solutions that combine to deliver on our unswerving belief that ideas need to become solutions, fast. Because humanity needs solutions, fast.
Ensysce Biosciences
Case Study
Request a copy of our latest case study with Ensysce Biosciences about how our integrated strategies helped them achieve their regulatory milestones faster for PF614-MPAR, an Extended Release product.
Endevica Bio
Case Study
Request a copy of our case study with Endevica Bio on how Translational Pharmaceutics successfully supported a novel synthetic peptide product with an integrated pharmacy compounding approach.
Corcept Therapeutics
Case Study
Our unique ability to integrate clinical manufacturing and clinical trial dosing at the same location helped the development of next-generation medicine.
Stealth BioTherapeutics
Case Study
Using our Translational Pharmaceutics® platform, Stealth BioTherapeutics found that it was exactly the cost-effective, rapid delivery program they needed.
Druggability Technologies (DRGT) Case Study
DRGT partnered with us to accelerate their drug product development from early phase to scale-up and commercialization.
BioCryst Pharmaceuticals Case Study
BioCryst partnered with us as they needed reassurance from their drug development partner that delivery timelines could be met.
MEI Pharma Case Study
MEI Pharma has leveraged Quotient's Translational Pharmaceutics® platform to expedite the development of its next-generation cancer therapy.
Pulmatrix Case Study
Breathing new life into Phase 1 trials. Our approach helped Pulmatrix to develop a range of inhaled dry powder chemical entities based on its iSPERSE™ technology.
Clovis Oncology Case Study
Clovis Oncology chose our drug product optimization approach for rociletinib, a promising oral candidate drug for the treatment of lung cancer.
Services:
Clinical Manufacturing
Xspray Pharma Case Study
Solving insolubility. Find out how our Translational Pharmaceutics® platform helped accelerate Xspray's Phase I Study, reducing the required dose.
Supporting Case Studies
-
Case StudiesThermal Rearrangement - Flow Chemistry Case StudyQuotient Sciences seeking to improve the yield and purity of a US Biotech API intermediate using flow chemistry
-
Case StudiesAPI Development Case StudyRapid development of a scalable route towards an analogue of a new drug substance, with definition of an optimal salt form for formulation
-
Case StudiesBiochemical Assay Optimization, Validation & Application Case StudyUK specialty-pharma company in need of biochemical assay for their regulatory non-clinical safety study
-
Case StudiesStable Isotope Labelling Case StudyMultiple, biotechnology and large-pharma companies needing isotope labelling support for their ADME/hAME studies
-
Case StudiesRadiosynthesis via chemically unstable intermediate Case StudyUS biopharmaceutical company seeking to improve stability of their chemically unstable API intermediate for radiochemical trials
-
Case StudiesAnalytical and Microbiological support Case StudyUK Clinical Research Unit (CRU), developing intravenous (IV) products in need of analytical & microbiological support
-
Case StudiesAnalysis of Insulin Analogues Case StudyEuropean biotech company developing an NCE to fulfil an unmet patient need, required insulin analogue analysis to gain regulatory approval
-
Case StudiesDrug Substance Salt Selection Case StudyUS Biopharmaceutical seeking drug substance and salt screen selection for their molecule.